Some studies have shown that exosomal lncRNA ARSR could competitively bind to miR-34 and miR-449 to regulate the expression of AXL, c-MET, and then promoted the drug resistance of renal cell carcinoma [37]. This evidence concerns the gene AXL and renal cell carcinoma.